Dancheng County Huatai Biotechnology Co., Ltd. (manufacturer), established in 2001, possesses a modern production facility spanning 20,000 square meters, equipped with comprehensive production and testing equipment. It strictly implements the ISO9001-2000 quality assurance system, with both production processes and product quality meeting international excellence standards.

The company primarily focuses on the research, development, and production of active pharmaceutical ingredients (APIs) and novel pharmaceutical intermediates, forming capabilities from small-scale trials to pilot and industrial-scale production. It also engages in the research and development of new drug intermediates, technology transfer, and technical services. In collaboration with renowned chemical research institutions, the company has established laboratories and set up R&D centers.

The company has completed the research, pilot testing, and production of over two thousand types of pharmaceutical intermediates and dozens of APIs. It has developed several major product systems—heterocyclic compounds (piperidine series, pyrrolidine series, piperazine series, imidazole series, thiazole series, pyrimidine series, indole series, etc.), cyclohexylamine compounds, boronic acids, phenylacetylenes, amino acids, and more.